Pharmacokinetics of dopamine-2 agonists in rats and dogs
โ Scribed by James E. Swagzdis; Robert W. Wittendorf; Robert M. Demarinis; Bruce A. Mico
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 515 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Pharmacokinetic compartment models were constructed to describe the absorption and metabolism of dopamine (DA) and DA prodrug, N-(N-acetyl-L-methionyl)O,O-bis(ethoxycarbonyl) dopamine( 1). Plasma concentrations of DA, DA-SO,, and DOPAC after oral administration of DA to dogs, were analysed using the
The pharmacokinetics of the dopamine D2 agonist S( -)-2-(N-propyl-N2-thienylethylamino)-5-hydroxytetralin (1, N-0923) after intravenous, intraperitoneal, and oral administration was studied in freely moving male and female albino Wistar rats. In all cases, the dose was
0 Tiqueside (CP-88,818, p-tigogenin cellobioside) is an effective cholesterol absorption inhibitor that may be useful in the treatment of hypercholesteremia. We have investigated the pharmacokinetics of tiqueside in dogs, rats, rabbits, and monkeys. In dogs, the volume of distribution (Vd, , ) was 2